ID   CHD8_RAT                Reviewed;        2581 AA.
AC   Q9JIX5;
DT   24-MAR-2009, integrated into UniProtKB/Swiss-Prot.
DT   24-MAR-2009, sequence version 2.
DT   24-JUL-2024, entry version 149.
DE   RecName: Full=Chromodomain-helicase-DNA-binding protein 8 {ECO:0000255|HAMAP-Rule:MF_03071};
DE            Short=CHD-8 {ECO:0000255|HAMAP-Rule:MF_03071};
DE            EC=3.6.4.12 {ECO:0000255|HAMAP-Rule:MF_03071};
DE   AltName: Full=ATP-dependent helicase CHD8 {ECO:0000255|HAMAP-Rule:MF_03071};
DE   AltName: Full=Axis duplication inhibitor;
DE            Short=Duplin;
GN   Name=Chd8 {ECO:0000255|HAMAP-Rule:MF_03071};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH CTNNB1.
RX   PubMed=10921920; DOI=10.1074/jbc.m004089200;
RA   Sakamoto I., Kishida S., Fukui A., Kishida M., Yamamoto H., Hino S.,
RA   Michiue T., Takada S., Asashima M., Kikuchi A.;
RT   "A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf
RT   activation and axis formation.";
RL   J. Biol. Chem. 275:32871-32878(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11744694; DOI=10.1074/jbc.m108433200;
RA   Kobayashi M., Kishida S., Fukui A., Michiue T., Miyamoto Y., Okamoto T.,
RA   Yoneda Y., Asashima M., Kikuchi A.;
RT   "Nuclear localization of Duplin, a beta-catenin-binding protein, is
RT   essential for its inhibitory activity on the Wnt signaling pathway.";
RL   J. Biol. Chem. 277:5816-5822(2002).
RN   [4]
RP   FUNCTION, SUMOYLATION AT LYS-609, INTERACTION WITH PIAS3, AND MUTAGENESIS
RP   OF LYS-457; LYS-512; LYS-609 AND LYS-654.
RX   PubMed=16452319; DOI=10.1093/jb/mvj033;
RA   Yamashina K., Yamamoto H., Chayama K., Nakajima K., Kikuchi A.;
RT   "Suppression of STAT3 activity by Duplin, which is a negative regulator of
RT   the Wnt signal.";
RL   J. Biochem. 139:305-314(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1420; SER-1424; SER-1995;
RP   SER-1997; SER-2068; SER-2070 AND SER-2223, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: DNA helicase that acts as a chromatin remodeling factor and
CC       regulates transcription. Acts as a transcription repressor by
CC       remodeling chromatin structure and recruiting histone H1 to target
CC       genes. Suppresses p53/TP53-mediated apoptosis by recruiting histone H1
CC       and preventing p53/TP53 transactivation activity. Acts as a negative
CC       regulator of Wnt signaling pathway by regulating beta-catenin (CTNNB1)
CC       activity. Negatively regulates CTNNB1-targeted gene expression by being
CC       recruited specifically to the promoter regions of several CTNNB1
CC       responsive genes. Involved in both enhancer blocking and epigenetic
CC       remodeling at chromatin boundary via its interaction with CTCF. Acts as
CC       a suppressor of STAT3 activity by suppressing the LIF-induced STAT3
CC       transcriptional activity. Also acts as a transcription activator via
CC       its interaction with ZNF143 by participating in efficient U6 RNA
CC       polymerase III transcription. Regulates alternative splicing of a core
CC       group of genes involved in neuronal differentiation, cell cycle and DNA
CC       repair. Enables H3K36me3-coupled transcription elongation and co-
CC       transcriptional RNA processing likely via interaction with HNRNPL.
CC       {ECO:0000255|HAMAP-Rule:MF_03071, ECO:0000269|PubMed:11744694,
CC       ECO:0000269|PubMed:16452319}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03071};
CC   -!- SUBUNIT: Interacts with p53/TP53, histone H1 and CTCF. Component of
CC       some MLL1/MLL complex, at least composed of the core components
CC       KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the
CC       facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L,
CC       MAX, MCRS1, MGA, KAT8/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A,
CC       RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Interacts
CC       with CHD7. Interacts with FAM124B (By similarity). Interacts with
CC       CTNNB1 (PubMed:10921920). Interacts with PIAS3 (PubMed:16452319).
CC       Interacts with TLK2 (By similarity). Interacts with HNRNPL in an RNA-
CC       dependent manner. {ECO:0000250|UniProtKB:Q9HCK8, ECO:0000255|HAMAP-
CC       Rule:MF_03071, ECO:0000269|PubMed:10921920,
CC       ECO:0000269|PubMed:16452319}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03071,
CC       ECO:0000269|PubMed:10921920, ECO:0000269|PubMed:11744694}.
CC       Note=Localizes to the promoter regions of several CTNNB1-responsive
CC       genes. Also present at known CTCF target sites. {ECO:0000255|HAMAP-
CC       Rule:MF_03071}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9JIX5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9JIX5-2; Sequence=VSP_036678, VSP_036679;
CC   -!- PTM: Sumoylated. {ECO:0000255|HAMAP-Rule:MF_03071,
CC       ECO:0000269|PubMed:16452319}.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. CHD8 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03071}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF169825; AAF89678.1; -; mRNA.
DR   EMBL; CH474040; EDL88472.1; -; Genomic_DNA.
DR   RefSeq; NP_001334590.1; NM_001347661.1. [Q9JIX5-1]
DR   RefSeq; XP_006251973.1; XM_006251911.3.
DR   AlphaFoldDB; Q9JIX5; -.
DR   SMR; Q9JIX5; -.
DR   STRING; 10116.ENSRNOP00000071948; -.
DR   iPTMnet; Q9JIX5; -.
DR   PhosphoSitePlus; Q9JIX5; -.
DR   PaxDb; 10116-ENSRNOP00000022593; -.
DR   Ensembl; ENSRNOT00000096813.1; ENSRNOP00000096922.1; ENSRNOG00000025011.6. [Q9JIX5-2]
DR   GeneID; 65027; -.
DR   KEGG; rno:65027; -.
DR   UCSC; RGD:620696; rat. [Q9JIX5-1]
DR   AGR; RGD:620696; -.
DR   CTD; 57680; -.
DR   RGD; 620696; Chd8.
DR   VEuPathDB; HostDB:ENSRNOG00000025011; -.
DR   eggNOG; KOG0384; Eukaryota.
DR   GeneTree; ENSGT00940000153649; -.
DR   HOGENOM; CLU_000315_5_2_1; -.
DR   InParanoid; Q9JIX5; -.
DR   OrthoDB; 22878at2759; -.
DR   PhylomeDB; Q9JIX5; -.
DR   TreeFam; TF313572; -.
DR   Reactome; R-RNO-3769402; Deactivation of the beta-catenin transactivating complex.
DR   PRO; PR:Q9JIX5; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Proteomes; UP000234681; Chromosome 15.
DR   Bgee; ENSRNOG00000025011; Expressed in spleen and 19 other cell types or tissues.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0071339; C:MLL1 complex; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0070016; F:armadillo repeat domain binding; IPI:RGD.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0140658; F:ATP-dependent chromatin remodeler activity; ISS:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0003678; F:DNA helicase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0035064; F:methylated histone binding; ISS:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0048565; P:digestive tract development; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0006397; P:mRNA processing; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:2000270; P:negative regulation of fibroblast apoptotic process; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0045945; P:positive regulation of transcription by RNA polymerase III; ISS:UniProtKB.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0035176; P:social behavior; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd18668; CD1_tandem_CHD5-9_like; 1.
DR   CDD; cd18663; CD2_tandem_CHD5-9_like; 1.
DR   CDD; cd18060; DEXHc_CHD8; 1.
DR   CDD; cd18793; SF2_C_SNF; 1.
DR   Gene3D; 2.40.50.40; -; 2.
DR   Gene3D; 3.40.5.120; -; 1.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 3.40.50.10810; Tandem AAA-ATPase domain; 1.
DR   HAMAP; MF_03071; CHD8; 1.
DR   InterPro; IPR006576; BRK_domain.
DR   InterPro; IPR037259; BRK_sf.
DR   InterPro; IPR051493; CHD.
DR   InterPro; IPR034724; CHD8.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR023780; Chromo_domain.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR038718; SNF2-like_sf.
DR   InterPro; IPR049730; SNF2/RAD54-like_C.
DR   InterPro; IPR000330; SNF2_N.
DR   PANTHER; PTHR46850; CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 9; 1.
DR   PANTHER; PTHR46850:SF3; DNA HELICASE; 1.
DR   Pfam; PF07533; BRK; 1.
DR   Pfam; PF00385; Chromo; 2.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00176; SNF2-rel_dom; 1.
DR   SMART; SM00592; BRK; 2.
DR   SMART; SM00298; CHROMO; 2.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF160481; BRK domain-like; 1.
DR   SUPFAM; SSF54160; Chromo domain-like; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS50013; CHROMO_2; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; ATP-binding; Chromatin regulator;
KW   DNA-binding; Helicase; Hydrolase; Isopeptide bond; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation;
KW   Wnt signaling pathway.
FT   CHAIN           1..2581
FT                   /note="Chromodomain-helicase-DNA-binding protein 8"
FT                   /id="PRO_0000367311"
FT   DOMAIN          642..709
FT                   /note="Chromo 1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   DOMAIN          724..790
FT                   /note="Chromo 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   DOMAIN          823..997
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   DOMAIN          1137..1288
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   REGION          22..114
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          253..281
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          349..375
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          473..584
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          596..616
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1692..1713
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1789..2302
FT                   /note="Interaction with FAM124B"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   REGION          1988..2016
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2047..2118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2179..2221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2484..2581
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           948..951
FT                   /note="DEAH box"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   COMPBIAS        43..69
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        89..114
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        357..371
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        488..521
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        560..584
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1692..1710
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2074..2093
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2094..2116
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2491..2511
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2515..2531
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2537..2553
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         836..843
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   MOD_RES         432
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         553
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         1420
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1976
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         1978
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         1993
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         1995
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1997
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2008
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         2068
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2070
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2182
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         2200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         2202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q09XV5"
FT   MOD_RES         2204
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q09XV5"
FT   MOD_RES         2211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   MOD_RES         2215
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q09XV5"
FT   MOD_RES         2223
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2519
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   CROSSLNK        609
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03071"
FT   CROSSLNK        2025
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   CROSSLNK        2256
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HCK8"
FT   VAR_SEQ         743..749
FT                   /note="PVIYYLV -> VSWAQRV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10921920"
FT                   /id="VSP_036678"
FT   VAR_SEQ         750..2581
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10921920"
FT                   /id="VSP_036679"
FT   MUTAGEN         457
FT                   /note="K->R: Does not affect sumoylation status."
FT                   /evidence="ECO:0000269|PubMed:16452319"
FT   MUTAGEN         512
FT                   /note="K->R: Does not affect sumoylation status."
FT                   /evidence="ECO:0000269|PubMed:16452319"
FT   MUTAGEN         609
FT                   /note="K->R: Induces a decrease in sumoylation status."
FT                   /evidence="ECO:0000269|PubMed:16452319"
FT   MUTAGEN         654
FT                   /note="K->R: Does not affect sumoylation status."
FT                   /evidence="ECO:0000269|PubMed:16452319"
SQ   SEQUENCE   2581 AA;  290692 MW;  4E2BBE55D7A2CD3D CRC64;
     MADPIMDLFD DPNLFGLDSL TDDSFNQVTQ DPIEEALGLP SSLDSLDQMN QDGGSGDVGN
     SSASDLVPPP EETASTELPK ESTAPAPESL TLHDYTTQPT SQEQPAQPVL QTSTPTSGLL
     QVSKSQEILS QGNPFMGVSA TAVSPSNTGG QPSQSAPKIV ILKAPPNSSV TGAHVAQIQA
     QGITSTAQPL VAGTANGGKV TFTKVLTGTP LRPGVSIVSG NTVLATKVPG NQAAVQRIVQ
     PSRPVKQLVL QPVKGSAPAG NPGATGPPLK PAVTLTSTPA QGESKRITLV LQQPQSGGPQ
     GHRHVVLGSL PGKIVLQGNQ LAALTQAKSA QGQPAKVVTI QLQVQQPQQK IQIVPQPPSS
     QPQPQPPPSA QPLTLSSVQQ AQIMGPGQNP GQRLSVPLKM VLQPQAGSSQ GASSGLSVVK
     VLSASEVAAL SSPASCAPHT AGKTGMEENR RLEHQKKQEK ANRIVAEAIA RARARGEQNI
     PRVLNEDELP SVRPEEEGEK KRRKKSSGER LKEEKPKKSK TAAASKTKGK SKLNTITPVV
     GKKRKRNTSS DNSDVEVMPA QSPREDEESS IQKRRSNRQV KRKKYTEDLD IKITDDEEEE
     EVDVTGPIKP EPILPEPVPE PDGETLPSMQ FFVENPSEED AAIVDKVLSM RVVKKELPSG
     QYTEAEEFFV KYKNYSYLHC EWATISQLEK DKRIHQKLKR FKTKMAQMRH FFHEDEEPFN
     PDYVEVDRIL DESHSVDKDN GEPVIYYLVK WCSLPYEDST WELKEDVDEG KIREFKRIQS
     RHPELKRVNR PQANAWKKLE LSHEYKNRNQ LREYQLEGVN WLLFNWYNRQ NCILADEMGL
     GKTIQSIAFL QEVYNVGIHG PFLVIAPLST ITNWEREFNT WTEMNTIVYH GSLASRQMIQ
     QYEMYCKDSR GRLIPGAYKF DALITTFEMI LSDCPELREI EWRCVIIDEA HRLKNRNCKL
     LDSLKHMDLE HKVLLTGTPL QNTVEELFSL LHFLEPSQFP SESEFLKDFG DLKTEEQVQK
     LQAILKPMML RRLKEDVEKN LAPKQETIIE VELTNIQKKY YRAILEKNFS FLSKGAGHTN
     MPNLLNTMME LRKCCNHPYL INGAEEKILM EFREACHIIP QDFHLQAMVR SAGKLVLIDK
     LLPKLKAGGH KVLIFSQMVR CLDILEDYLI QRRYLYERID GRVRGNLRQA AIDRFSKPDS
     DRFVFLLCTR AGGLGINLTA ADTCIIFDSD WNPQNDLQAQ ARCHRIGQSK AVKVYRLITR
     NSYEREMFDK ASLKLGLDKA VLQSMSGRDG NITGIQQFSK KEIEDLLRKG AYAAIMEEDD
     EGSKFCEEDI DQILLRRTTT ITIESEGKGS TFAKASFVAS ENRTDISLDD PNFWQKWAKK
     ADLDMDLLNS KNNLVIDTPR VRKQTRHFST LKDDDLVEFS DLESEDDERP RSRRHDRHHT
     YGRTDCFRVE KHLLVYGWGR WRDILSHGRF KRRMTERDVE TICRAILVYC LLHYRGDENI
     KSFIWDLISP AENGKTKELQ NHSGLSIPVP RGRKGKKVKS QSTFDIHKAD WIRKYNPDTL
     FQDESYKKHL KHQCNKVLLR VRMLYYLRQE VIGDQAEKVL GGAIASEIDI WFPVVDQLEV
     PTTWWDSEAD KSLLIGVFKH GYEKYNTMRA DPALCFLEKA GRPDDKAIAA EHRVLDNFSD
     LVEGIDFDKD CEDPEYKPLQ GPPKDPDDEG DPLMMMDEEI SVIDGDEAPV TQQPGHLFWP
     PGSALTARLR RLVTAYQRSY KREQMKIEAA ERGDRRRRRC EAAFKLKEIA RREKQQRWTR
     REQTDFYRVV STFGVEYDPD NMQFHWDRFR TFARLDKKTD ESLTKYFHGF VAMCRQVCRL
     PPAAGDEPPD PNLFIEPITE ERASRTLYRI ELLRRLREQV LCHPLLEDRL ALCQPPGLEL
     PKWWEPVRHD GELLRGAARH GVSQTDCNIM QDPDFSFLAA RMNYMQNHQA GASAASLSRC
     STPLLHQQCT SRTASPSPLR PDVPAEKSPE ENAVQVPSLD SLTLKLEDEV VARSRLTPQD
     YEIRVASSDT APLSRSVPPV KLEDDDDSDS ELDLSKLSPS SSSSSSSSSS SSSSDESEDE
     KEEKLTADRS RPKLYDEESL LSLTMSQDGF PNEDGEQMTP ELLLLQERQR ASEWPKDRVL
     INRIDLVCQA VLSGKWPSNR RSQEMTTGGI LGPGNHLLDS PSLTPGEYGD SPVPTPRSSS
     AASMVEEEAS AVTTAAAQFT KLRRGMDEKE FTVQIKDEEG LKLTFQKHRL MANGVMGDGH
     PLFHKKKGNR KKLVELEVEC MEEPNHLDVD LETRIPVINK VDGTLLVGDE APRRAELDMW
     LQGHPEFAVD PRFLAYMEER RKQKWQRCKK NNKTELNCLG MEPVQPANSR NGKKGHYAET
     AFNRVLPGPI APENSKKRVR RTRPDLSKMM ALMQGGSTGS LSLHNTFQHS SSNLQSVSSL
     GHSSATSASL PFMPFVMGGA AAPPHVDSST MLHHHHHHPH PHHHHHHHPG LRTTGYPSSP
     ATTTSGTALR LPTLQHEDDD EEEDEDDDDL SQGYDSSERD FSLIDDPMMP ANSDSSDDAD
     D
//
